Data as of Nov 4, 2026.
AOTG vs FMED: Holdings Overlap & Returns
Over the year to Nov 4, 2026, AOTG returned +3.2% to FMED's +27.4%; 0% of their weight is in the same names.
askIQ about this page
askIQ about AOTG and FMED
Net assets: $105m on Aug 31, 2026 for AOT Growth and Innovation ETF, and $52m on Sep 30, 2026 for Fidelity Disruptive Medicine ETF.
74% of AOTG's weight is in S&P 500 companies and 26% is outside the index. Holdings as of Aug 31, 2026.
22% of FMED's weight is in S&P 500 companies and 78% is outside the index. Holdings as of Aug 31, 2026.
Pair scorecard
FMED costs 0.25 points a year less; their one-year returns differ by 24.2 points; AOTG is 2.0 times larger.
Points (pts) are percentage points.
| Measure | AOTG | FMED |
|---|---|---|
| Return | ||
| Total return, 1 year | +3.2% | +27.4% |
| Drawdown | ||
| Below its all-time high | 14.7%, high on Oct 7, 2026 | |
| Against its benchmark | ||
| What it tracks | Broad innovation and megatrends | Broad innovation and megatrends |
| Its benchmark, total return, 1 year | +14.4% | |
| Against its benchmark, 1 year | behind by 11.2 pts | |
| Cost and size | ||
| Expense ratio | 0.75% | 0.50% |
| Net assets, as of Aug 31, 2026 | $105m | $52m |
| Holdings | ||
| Holdings in common | 0% | |
| Top ten holdings, share of the fund | 64% | 33% |
What they share
By the books each fund has filed, AOTG and FMED hold 0% of their money in the same securities at the same weight. Holdings dated Aug 31, 2026.
half
0% in common
Only in one fund ↓
Window by window
| Total return | vs its benchmark | |||
|---|---|---|---|---|
| Window | AOTG | FMED | AOTG | FMED |
| 3 months | −7.6% | +14.9% | −7.1 pts vs GUSA | not measured |
| 6 months | −1.1% | +31.2% | −5.8 pts vs GUSA | not measured |
| 1 year | +3.2% | +27.4% | −11.2 pts vs GUSA | not measured |
| 3 years | +101.5% | +57.8% | +19.6 pts vs GUSA | not measured |
| Since launchNot the same days: AOTG Jun 2022 · FMED Jun 2023 | +139.7% | +31.7% | +29.2 pts vs GUSA | not measured |
Side by side
As of Nov 4, 2026. Source: ETFIQ.
0% of the two portfolios are the same securities at the same weight.
Over the year to Nov 4, 2026 the fund returned +3.2% with distributions reinvested against +14.4% for its benchmark, the Solactive GBS United States 1000 Index, so a holder was behind by 11.2 pts.
By weight, 74% of AOTG's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 69%. The top ten holdings are 64% of the fund across 43 positions, as filed for Aug 31, 2026. It sits 14.7% below its all-time high of Oct 7, 2026.
FMED
By weight, 22% of FMED's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 33% of the fund across 72 positions, as filed for Aug 31, 2026. Over the year to Nov 4, 2026 the fund returned +27.4% with distributions reinvested.
Questions people ask
- Do AOTG and FMED hold the same stocks?
- By their latest filings, 0% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Links are sources, not endorsements. A comparison is not a recommendation.
How this is computed
Overlap adds up the smaller of the two weights for each security both funds hold.
Every number is an ETFIQ calculation with distributions reinvested.
Cite this pageCitation, APA and Markdown
ETFIQ, AOTG against FMED, data as of Nov 4, 2026. https://etfiq.com/compare/themes/aotg-vs-fmed
ETFIQ. (Nov 4, 2026). AOTG against FMED. Retrieved from https://etfiq.com/compare/themes/aotg-vs-fmed
[AOTG against FMED (ETFIQ, Nov 4, 2026)](https://etfiq.com/compare/themes/aotg-vs-fmed)
Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.